Medical Oncology

Pharmacology

Questions discussed in this category

Do you stop PPI when starting patients on immunotherapy?

1 Answer available

How would you approach a patient who has developed neutropenia with the combination of trastuzumab/pertuzumab in the adjuvant setting?

Would you consider the discontinuation of either anti-HER2 agent or both?

1 Answer available

What is your approach to the management of hot flashes in a patient who wants to use herbal medicine?

Do you allow patients with breast cancer on tamoxifen to use black cohosh?

2 Answers available

What is the best way to approach elevated liver enzymes in patients treated with combination TKI and immunotherapy?

Are there any clinical features that can inform etiology/which medication to hold?

1 Answer available

Papers discussed in this category

Br J Cancer, 2020 Jun 26

Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events.

Ann Pharmacother, 2021 Jul 20

Impact of Proton Pump Inhibitor Use on the Effectiveness of Immune Checkpoint Inhibitors in Advanced Cancer Patients.

Ann Transl Med,

The effect of proton pump inhibitor uses on outcomes for cancer patients treated with immune checkpoint inhibitors: a meta-analysis.

Can Fam Physician,

Deprescribing proton pump inhibitors: Evidence-based clinical practice guideline.

Related Topics in Medical Oncology